ArticleEClinicalMedicine2021

Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial.

Peter R Feldman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.